Identification of candidate methylation-responsive genes in ovarian cancer

Laura Menendez, De Ette Walker, Lilya V. Matyunina, Erin B. Dickerson, Nathan J. Bowen, Nalini Polavarapu, Benedict B. Benigno, John F. McDonald

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Background: Aberrant methylation of gene promoter regions has been linked to changes in gene expression in cancer development and progression. Genes associated with CpG islands (CGIs) are especially prone to methylation, but not all CGI-associated genes display changes in methylation patterns in cancers. Results: In order to identify genes subject to regulation by methylation, we conducted gene expression profile analyses of an ovarian cancer cell line (OVCAR-3) before and after treatment with the demethylating agent 5-aza-deoxycytidine (5-aza-dC). An overlapping subset of these genes was found to display significant differences in gene expression between normal ovarian surface epithelial cells and malignant cells isolated from ovarian carcinomas. While 40% of all human genes are associated with CGIs, > 94% of the overlapping subset of genes is associated with CGIs. The predicted change in methylation status of genes randomly selected from the overlapping subset was experimentally verified. Conclusion: We conclude that correlating genes that are upregulated in response to 5-aza-dC treatment of cancer cell lines with genes that are down-regulated in cancer cells may be a useful method to identify genes experiencing epigenetic-mediated changes in expression over cancer development.

Original languageEnglish (US)
Article number10
JournalMolecular Cancer
StatePublished - 2007


Dive into the research topics of 'Identification of candidate methylation-responsive genes in ovarian cancer'. Together they form a unique fingerprint.

Cite this